| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Muscle tissue; Cellulitis from ORIGENE TECHNOLOGIES | CS608851 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Muscle tissue; Cellulitis from ORIGENE TECHNOLOGIES | CS608852 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Muscle tissue; Degenerative joint disease from ORIGENE TECHNOLOGIES | CS705219 | 5x5um | ORIGENE TECHNOLOGIES |
| TCEA2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH322661 | 10 ug | ORIGENE TECHNOLOGIES |
| TCEA3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH308347 | 10 ug | ORIGENE TECHNOLOGIES |
| TCEANC2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406749 | 1 kit | ORIGENE TECHNOLOGIES |
| TCEANC - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412011 | 1 kit | ORIGENE TECHNOLOGIES |
| Tceanc - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517311 | 1 kit | ORIGENE TECHNOLOGIES |
| Tceanc2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517312 | 1 kit | ORIGENE TECHNOLOGIES |
| TCEB3B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406005 | 1 kit | ORIGENE TECHNOLOGIES |
| TCEB3C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419664 | 1 kit | ORIGENE TECHNOLOGIES |
| TCEB2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401393 | 1 kit | ORIGENE TECHNOLOGIES |
| TCEB1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401950 | 1 kit | ORIGENE TECHNOLOGIES |
| TCEB3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402462 | 1 kit | ORIGENE TECHNOLOGIES |
| Tceb1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517313 | 1 kit | ORIGENE TECHNOLOGIES |
| Tceb2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517314 | 1 kit | ORIGENE TECHNOLOGIES |
| Tceb3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517315 | 1 kit | ORIGENE TECHNOLOGIES |
| TCEB2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301393 | 10 ug | ORIGENE TECHNOLOGIES |
| TCEB2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH319239 | 10 ug | ORIGENE TECHNOLOGIES |
| T-cell activation RhoGTPase activating protein (TAGAP), transcript variant 1 from ORIGENE TECHNOLOGIES | LY407719 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell activation RhoGTPase activating protein (TAGAP), transcript variant 3 from ORIGENE TECHNOLOGIES | LY408495 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell acute lymphocytic leukemia 1 (TAL1) from ORIGENE TECHNOLOGIES | LY418842 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell acute lymphocytic leukemia 2 (TAL2) from ORIGENE TECHNOLOGIES | LY417315 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 (TCIRG1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416888 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 (TCIRG1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416905 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 (TCIRG1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429280 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell immunoglobulin and mucin domain containing 4 (TIMD4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY408645 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell immunoglobulin and mucin domain containing 4 (TIMD4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431308 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin-like 5 (UBL5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420793 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) from ORIGENE TECHNOLOGIES | LY407258 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin-like with PHD and ring finger domains 1 (UHRF1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420780 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin-like with PHD and ring finger domains 1 (UHRF1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY415692 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin-like with PHD and ring finger domains 1 (UHRF1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429374 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3A (UBE3A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400164 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3A (UBE3A), transcript variant 3 from ORIGENE TECHNOLOGIES | LY408892 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3B (UBE3B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY408916 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3 component n-recognin 7 (putative) (UBR7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403580 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3 component n-recognin 7 (putative) (UBR7), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420256 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3 component n-recognin 7 (putative) (UBR7), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426111 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3 component n-recognin 1 (UBR1) from ORIGENE TECHNOLOGIES | LY406398 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin protein ligase E3C (UBE3C) from ORIGENE TECHNOLOGIES | LY415125 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin related modifier 1 homolog (S. cerevisiae) (URM1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410664 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase 7 (herpes virus-associated) (USP7) from ORIGENE TECHNOLOGIES | LY401171 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase 13 (isopeptidase T-3) (USP13) from ORIGENE TECHNOLOGIES | LY401292 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase 5 (isopeptidase T) (USP5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420633 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase 5 (isopeptidase T) (USP5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426027 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase 5 (isopeptidase T) (USP5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418652 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase like 1 (USPL1) from ORIGENE TECHNOLOGIES | LY401761 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase 4 (proto-oncogene) (USP4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418737 | 100 ug | ORIGENE TECHNOLOGIES |
| Ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) (USP14), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417492 | 100 ug | ORIGENE TECHNOLOGIES |